Surgeon preferences for self-treatment in locally advanced non-small cell lung cancer: Would we practice what we preach?
- PMID: 39387733
- DOI: 10.1016/j.jtcvs.2024.05.029
Surgeon preferences for self-treatment in locally advanced non-small cell lung cancer: Would we practice what we preach?
Keywords: adjuvant; chemotherapy; immunotherapy; lung cancer; multimodal treatment; neoadjuvant; perioperative; surgery; targeted therapy.
Conflict of interest statement
Conflict of Interest Statement Dr Brunelli receives consulting fees from Astra Zeneca, MSD, BMS, Ethicon, Medtronic, and Roche. Dr Petersen receives consulting fees from Medtronic, AstraZeneca, AMBU, Medela. Advisory Board AstraZeneca, BMS, Roche, and MSD. Dr Wigle receives consulting fees from Intuitive Surgical and Genentech. All other authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
Publication types
LinkOut - more resources
Full Text Sources
